FDA Eyes Manufacturing Innovation to Boost Drug Development

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-05-02-2004, Volume 28, Issue 5

New technologies, along with changes in FDA oversight, may provide a critical path to make more new drugs available more quickly to patients.

Related Content:

ManufacturingQuality SystemsRegulatory WatchPharmaceutical Technology-05-02-2004
Using Continuous Processes and Automation to Remove Contamination Risk
Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia
FDA Releases Draft Guidance on Sampling and Testing of In-Process Materials and Drug Products